Zoetis Investor Day targets mid-to-high single-digit revenue growth, $1B+ peak OA pain franchise

Zoetis Inc.

Annual revenue growth target of mid-to-high single digits over next 3-5 years.
Osteoarthritis pain franchise expected to exceed $1B in peak sales.
Existing billion-dollar franchises in dermatology and pet parasiticides to be expanded.
Drive ROIC accretion and margin improvement through revenue growth and global scale leverage.
Disciplined capital allocation balancing investments and return of capital.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.